When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVS - Remdesivir Success Will Trigger BioCryst Surge
Novartis AG
Galidesivir, not berotralstat, will be the BCRX catalyst
Oral berotralstat is soon likely to gain approval in three regions - Japan, the U.S., and Europe - for the treatment of HAE. In Japan, a new drug application for berotralstat is currently being reviewed by the Pharmaceuticals and Medical Devices Agency, and BioCryst (BCRX) expects approval in H2 2020. In the U.S., the Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) date of December 3, 2020. BCRX's Chief Medical Officer, William P. Sheridan, says of the FDA approval